1 Min Read
March 29 (Reuters) - Astrazeneca Plc
* Potential medicine for neuromyelitis optica spectrum disorder receives orphan designation in europe Source text for Eikon: Further company coverage: (Reporting By London Bureau)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.